SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

24 Jul 2024 Evaluate
The Sales for the quarter ended June 2024 of Rs. 1489.63 millions rose by 36.67% from Rs. 1089.92 millions.The Net Profit of the company vaulted to 159.08% to Rs. 194.21  millions from Rs. 74.96 millions in the previous quarter.Operating Profit saw a handsome growth to 335.83 millions from 175.78 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1489.63 1089.92 36.67 1489.63 1089.92 36.67 6054.60 5983.40 1.19
Other Income 68.41 65.27 4.81 68.41 65.27 4.81 335.01 507.66 -34.01
PBIDT 335.83 175.78 91.05 335.83 175.78 91.05 1406.68 1409.21 -0.18
Interest 11.68 13.09 -10.77 11.68 13.09 -10.77 58.06 100.56 -42.26
PBDT 324.15 162.69 99.24 324.15 162.69 99.24 937.76 1308.65 -28.34
Depreciation 62.61 53.64 16.72 62.61 53.64 16.72 235.19 151.73 55.01
PBT 261.54 109.05 139.83 261.54 109.05 139.83 702.57 1156.92 -39.27
TAX 67.33 34.09 97.51 67.33 34.09 97.51 196.13 302.14 -35.09
Deferred Tax -2.95 7.00 -142.14 -2.95 7.00 -142.14 -75.49 -42.10 79.31
PAT 194.21 74.96 159.08 194.21 74.96 159.08 506.44 854.78 -40.75
Equity 104.88 104.22 0.63 104.88 104.22 0.63 104.69 104.15 0.52
PBIDTM(%) 22.54 16.13 39.79 22.54 16.13 39.79 23.23 23.55 -1.35

Bliss GVS Pharma Share Price

258.35 -0.95 (-0.37%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×